HU197894B - Process for producing 4-acetyl-1-methyl-7-/4-pyridyl/-5,6,7,8-tetrahydro-3/2h/-isoquinolinone - Google Patents
Process for producing 4-acetyl-1-methyl-7-/4-pyridyl/-5,6,7,8-tetrahydro-3/2h/-isoquinolinone Download PDFInfo
- Publication number
- HU197894B HU197894B HU87535A HU53587A HU197894B HU 197894 B HU197894 B HU 197894B HU 87535 A HU87535 A HU 87535A HU 53587 A HU53587 A HU 53587A HU 197894 B HU197894 B HU 197894B
- Authority
- HU
- Hungary
- Prior art keywords
- pyridyl
- acetyl
- methyl
- tetrahydro
- isoquinolinone
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 title description 5
- GCPWJFKTWGFEHH-UHFFFAOYSA-N acetoacetamide Chemical compound CC(=O)CC(N)=O GCPWJFKTWGFEHH-UHFFFAOYSA-N 0.000 claims abstract description 9
- HWHKJOULOUZDEU-UHFFFAOYSA-N 2-acetyl-4-pyridin-4-ylcyclohexan-1-one Chemical compound C1CC(=O)C(C(=O)C)CC1C1=CC=NC=C1 HWHKJOULOUZDEU-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 3
- IIBDUHHNKOFCHQ-UHFFFAOYSA-N 4-acetyl-1-methyl-7-pyridin-2-yl-5,6,7,8-tetrahydro-2h-isoquinolin-3-one Chemical compound C1C2=C(C)NC(=O)C(C(=O)C)=C2CCC1C1=CC=CC=N1 IIBDUHHNKOFCHQ-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 9
- HZFHHFAPODBZDO-UHFFFAOYSA-N 2-(2-acetylpyridin-4-yl)cyclohexan-1-one Chemical compound C1=NC(C(=O)C)=CC(C2C(CCCC2)=O)=C1 HZFHHFAPODBZDO-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 239000000496 cardiotonic agent Substances 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229930185107 quinolinone Natural products 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 239000000203 mixture Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000002904 solvent Substances 0.000 description 10
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- NVTWQACIVZHUPA-UHFFFAOYSA-N 4-acetyl-1-methyl-7-pyridin-4-yl-5,6,7,8-tetrahydro-2h-isoquinolin-3-one Chemical compound C1C2=C(C)NC(=O)C(C(=O)C)=C2CCC1C1=CC=NC=C1 NVTWQACIVZHUPA-UHFFFAOYSA-N 0.000 description 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 239000012264 purified product Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000010446 mirabilite Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 4
- ALQFTBSPRXKAAU-UHFFFAOYSA-N 4-acetyl-2h-isoquinolin-1-one Chemical class C1=CC=C2C(C(=O)C)=CNC(=O)C2=C1 ALQFTBSPRXKAAU-UHFFFAOYSA-N 0.000 description 3
- RSDGRRJTGIGGBP-UHFFFAOYSA-N 4-pyridin-4-ylcyclohexan-1-one Chemical compound C1CC(=O)CCC1C1=CC=NC=C1 RSDGRRJTGIGGBP-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- GBCKMCXGDXVDPG-UHFFFAOYSA-N dimethyl 4-pyridin-4-ylheptanedioate Chemical compound COC(=O)CCC(CCC(=O)OC)C1=CC=NC=C1 GBCKMCXGDXVDPG-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 229960003712 propranolol Drugs 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- IOEPOEDBBPRAEI-UHFFFAOYSA-N 1,2-dihydroisoquinoline Chemical compound C1=CC=C2CNC=CC2=C1 IOEPOEDBBPRAEI-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RAEAJTHPRXWYMJ-UHFFFAOYSA-N 3-acetyl-4-methyl-6-pyridin-4-yl-5,6,7,8-tetrahydro-1h-quinolin-2-one Chemical compound C1C2=C(C)C(C(=O)C)=C(O)N=C2CCC1C1=CC=NC=C1 RAEAJTHPRXWYMJ-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- -1 alkali metal alcohols Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- CMQCNTNASCDNGR-UHFFFAOYSA-N toluene;hydrate Chemical compound O.CC1=CC=CC=C1 CMQCNTNASCDNGR-UHFFFAOYSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61026970A JPS62187467A (ja) | 1986-02-12 | 1986-02-12 | ４−アセチルイソキノリノン化合物の新規製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT44532A HUT44532A (en) | 1988-03-28 |
| HU197894B true HU197894B (en) | 1989-06-28 |
Family
ID=12208012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU87535A HU197894B (en) | 1986-02-12 | 1987-02-11 | Process for producing 4-acetyl-1-methyl-7-/4-pyridyl/-5,6,7,8-tetrahydro-3/2h/-isoquinolinone |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4814458A (en, 2012) |
| EP (1) | EP0236754B1 (en, 2012) |
| JP (1) | JPS62187467A (en, 2012) |
| KR (1) | KR890001241B1 (en, 2012) |
| CN (1) | CN1007622B (en, 2012) |
| AU (1) | AU578858B2 (en, 2012) |
| CA (1) | CA1286674C (en, 2012) |
| DE (1) | DE3764494D1 (en, 2012) |
| DK (1) | DK60287A (en, 2012) |
| FI (1) | FI85585C (en, 2012) |
| HU (1) | HU197894B (en, 2012) |
| NO (1) | NO167457C (en, 2012) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2515119A1 (en) | 2003-02-07 | 2004-08-19 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivative |
| US8280673B2 (en) | 2007-12-04 | 2012-10-02 | Honeywell International Inc. | System for determining ambient temperature |
| US9335769B2 (en) | 2007-12-04 | 2016-05-10 | Honeywell International Inc. | System for determining ambient temperature |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3480634A (en) * | 1966-02-28 | 1969-11-25 | Hoffmann La Roche | 1,4-dihydro-3(2h)-isoquinolones and process for their preparation |
| JPS61291570A (ja) * | 1985-06-19 | 1986-12-22 | Mitsui Toatsu Chem Inc | イソキノリン誘導体 |
| JPS624266A (ja) * | 1985-07-01 | 1987-01-10 | Mitsui Toatsu Chem Inc | 新規４−ピリジル−４−シアノピメリン酸エステルおよびその製造法 |
| JPS624265A (ja) * | 1985-07-01 | 1987-01-10 | Mitsui Toatsu Chem Inc | 新規４−ピリジルピメリン酸エステルおよびその製造法 |
| JPS625963A (ja) * | 1985-07-02 | 1987-01-12 | Mitsui Toatsu Chem Inc | イソキノリン誘導体 |
| JPH06210063A (ja) * | 1993-01-14 | 1994-08-02 | Kousaku Ishikawa | パチンコゲーム機における持ち玉返却機構 |
-
1986
- 1986-02-12 JP JP61026970A patent/JPS62187467A/ja active Granted
-
1987
- 1987-02-02 FI FI870453A patent/FI85585C/fi not_active IP Right Cessation
- 1987-02-02 US US07/010,304 patent/US4814458A/en not_active Expired - Fee Related
- 1987-02-02 CA CA000528786A patent/CA1286674C/en not_active Expired - Lifetime
- 1987-02-05 DK DK060287A patent/DK60287A/da not_active Application Discontinuation
- 1987-02-06 DE DE8787101637T patent/DE3764494D1/de not_active Expired - Lifetime
- 1987-02-06 EP EP87101637A patent/EP0236754B1/en not_active Expired - Lifetime
- 1987-02-11 KR KR1019870001118A patent/KR890001241B1/ko not_active Expired
- 1987-02-11 HU HU87535A patent/HU197894B/hu not_active IP Right Cessation
- 1987-02-11 CN CN87100838A patent/CN1007622B/zh not_active Expired
- 1987-02-11 NO NO870543A patent/NO167457C/no unknown
- 1987-02-11 AU AU68686/87A patent/AU578858B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU6868687A (en) | 1987-08-13 |
| FI870453L (fi) | 1987-08-13 |
| DE3764494D1 (de) | 1990-10-04 |
| NO167457B (no) | 1991-07-29 |
| HUT44532A (en) | 1988-03-28 |
| KR890001241B1 (ko) | 1989-04-28 |
| AU578858B2 (en) | 1988-11-03 |
| DK60287D0 (da) | 1987-02-05 |
| EP0236754B1 (en) | 1990-08-29 |
| NO870543L (no) | 1987-08-13 |
| FI870453A0 (fi) | 1987-02-02 |
| FI85585C (fi) | 1992-05-11 |
| CA1286674C (en) | 1991-07-23 |
| DK60287A (da) | 1987-08-13 |
| CN1007622B (zh) | 1990-04-18 |
| JPS62187467A (ja) | 1987-08-15 |
| US4814458A (en) | 1989-03-21 |
| EP0236754A1 (en) | 1987-09-16 |
| KR870007917A (ko) | 1987-09-22 |
| NO167457C (no) | 1991-11-06 |
| FI85585B (fi) | 1992-01-31 |
| JPH041746B2 (en, 2012) | 1992-01-14 |
| CN87100838A (zh) | 1987-09-09 |
| NO870543D0 (no) | 1987-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2563521A1 (fr) | Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents antibacteriens les contenant | |
| JPS61251650A (ja) | （ｚ）−１−フエニル−１−ジエチルアミノカルボニル−２−アミノメチルシクロプロパン塩酸塩の製造方法 | |
| US2540218A (en) | 2-hydroxy-pyridine-n-oxide and process for preparing same | |
| JP3839813B2 (ja) | カンプトテシン誘導体の調製に有用な化合物 | |
| US4639521A (en) | Isoquinoline derivatives | |
| HU197894B (en) | Process for producing 4-acetyl-1-methyl-7-/4-pyridyl/-5,6,7,8-tetrahydro-3/2h/-isoquinolinone | |
| US3201406A (en) | Pyridylcoumarins | |
| JPH0635458B2 (ja) | ピリドンカルボン酸誘導体、そのエステルおよびその塩 | |
| US4430342A (en) | N-Acyl-3-[4-(benzoylalkyl)piperazin-1-yl]-sydnonimine compound, process for prodction thereof, and use thereof | |
| NO137999B (no) | Analogifremgangsm}te ved fremstilling av terapeutisk aktive oxofurylestere av 6-(alfa-aminofenylacetamido)-penicillansyre | |
| JPS5817185B2 (ja) | ０↓−アミノメチルフエニル酢酸の製造方法 | |
| JPH0696572B2 (ja) | ピリドンカルボン酸誘導体、そのエステルおよびその塩 | |
| JP2831000B2 (ja) | （２−アミノベンゾイル）酢酸エステル誘導体 | |
| IL34468A (en) | Acidic salt salts of the history of indonopyridine, their preparation and pharmaceutical preparations containing them | |
| JP3315146B2 (ja) | アミノアルコール誘導体 | |
| JP3332171B2 (ja) | チエノ〔３，２−ｂ〕ピリジン誘導体の製造方法 | |
| JPH0674260B2 (ja) | キノリン誘導体、そのエステルおよびその塩 | |
| JPS5852995B2 (ja) | フルフラ−ル誘導体の製造法 | |
| KR840000961B1 (ko) | 환상 카르본산류의 제조방법 | |
| JPH0510344B2 (en, 2012) | ||
| HU188224B (en) | Process for preparing anthranyloyl-oxy-alkanoates | |
| JPS6127393B2 (en, 2012) | ||
| JPS6037117B2 (ja) | ６−アミノペニシラン酸誘導体の製法 | |
| JPS6087294A (ja) | ホスホン酸誘導体 | |
| JPS58103370A (ja) | ２−ニトロイミダゾ−ル類 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |